Increasing CTL Targeting of Conserved Sequences During Early HIV-1 Infection Is Correlated to Decreasing Viremia
Authors:
- 1 April 2011
- journal article
- Published by SAGE Publications in AIDS Research and Human Retroviruses
- Vol. 27 (4) , 391-398
Abstract
Early HIV-1 infection is marked by rapid evolution of both CD8 + T lymphocyte (CTL) epitope targeting and viral sequences, while chronic infection demonstrates relative stability of these parameters. To examine the interactions of changing CTL targeting and viremia in early infection, we assessed CTL targeting and viremia levels in persons during early HIV-1 infection (estimated 15–271 days post-infection) who were placed on effective antiretroviral therapy. Pre-therapy, CTL targeting of viral proteins varied between persons depending on time after infection. Across individuals, increasing time after infection was associated with increasing Gag and Pol targeting, suggesting increasing targeting of conserved sequences. The intensity of Gag targeting correlated to lower viremia levels, while Env targeting correlated to higher viremia levels during early infection. This suggested that shifted targeting towards more conserved sequences is involved with the drop of viremia during early infection, consistent with prior observations of correlation between Gag targeting and lower viremia during chronic infection. After suppressive antiretroviral therapy, CTL targeting was generally static, indicating that HIV-1 replication and evolution drives the evolution of CTL targeting in early infection. Overall, these data suggest that early CTL targeting is directed towards more variable epitopes, causing escape and re-targeting until more conserved epitopes are recognized stably in chronic infection. Circumventing this natural history by pre-targeting CTL against more conserved epitopes with a vaccine could minimize the initial period of viral escape and immune damage during acute infection, improving long-term containment of HIV-1.Keywords
This publication has 38 references indexed in Scilit:
- Candidate Vaccine Sequences to Represent Intra- and Inter-Clade HIV-1 VariationPLOS ONE, 2009
- Differential Neutralization of Human Immunodeficiency Virus (HIV) Replication in Autologous CD4 T Cells by HIV-Specific Cytotoxic T LymphocytesJournal of Virology, 2009
- Protective HLA Class I Alleles That Restrict Acute-Phase CD8+T-Cell Responses Are Associated with Viral Escape Mutations Located in Highly Conserved Regions of Human Immunodeficiency Virus Type 1Journal of Virology, 2009
- Primary Human Immunodeficiency Virus Type 1 (HIV-1) Infection during HIV-1 Gag VaccinationJournal of Virology, 2008
- Broad and Gag-Biased HIV-1 Epitope Repertoires Are Associated with Lower Viral LoadsPLOS ONE, 2008
- Selection on the Human Immunodeficiency Virus Type 1 Proteome following Primary InfectionJournal of Virology, 2006
- Genetic and Stochastic Influences on the Interaction of Human Immunodeficiency Virus Type 1 and Cytotoxic T Lymphocytes in Identical TwinsJournal of Virology, 2005
- Limited Sequence Evolution within Persistently Targeted CD8 Epitopes in Chronic Human Immunodeficiency Virus Type 1 InfectionJournal of Virology, 2005
- Parallel Human Immunodeficiency Virus Type 1-Specific CD8+T-Lymphocyte Responses in Blood and Mucosa during Chronic InfectionJournal of Virology, 2005
- Will we be able to ‘spot’ an effective HIV-1 vaccine?Trends in Immunology, 2003